MY148488A - Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists - Google Patents

Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists

Info

Publication number
MY148488A
MY148488A MYPI20050606A MY148488A MY 148488 A MY148488 A MY 148488A MY PI20050606 A MYPI20050606 A MY PI20050606A MY 148488 A MY148488 A MY 148488A
Authority
MY
Malaysia
Prior art keywords
additional
receptor antagonists
glutamate receptor
metabotropic glutamate
compounds
Prior art date
Application number
Other languages
English (en)
Inventor
Edwards Louise
Stefanec Tomislav
Stormann Thomas
Wensbo David
Tao Xin
Jalaj Arora
Isaac Methvin
Johansson Martin
Kers Annika
Malmberg Johan
Mcleod Donald
Minidis Alexander
Staaf Karin
Slassi Abdelmalik
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of MY148488A publication Critical patent/MY148488A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MYPI20050606 2004-02-18 2005-02-17 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists MY148488A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77986804A 2004-02-18 2004-02-18

Publications (1)

Publication Number Publication Date
MY148488A true MY148488A (en) 2013-04-30

Family

ID=36940522

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20050606 MY148488A (en) 2004-02-18 2005-02-17 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists

Country Status (2)

Country Link
AR (1) AR049472A1 (es)
MY (1) MY148488A (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9303024B2 (en) 2011-10-11 2016-04-05 Dana-Farber Cancer Institute, Inc. Pyrazol-3-ones that activate pro-apoptotic BAX
JP6434968B2 (ja) 2013-07-02 2018-12-05 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ Ｒｏｃｋ阻害剤としての三環式ピリド−カルボキサミド誘導体
US9663529B2 (en) 2013-07-02 2017-05-30 Bristol-Myers Squibb Company Tricyclic pyrido-carboxamide derivatives as rock inhibitors
AR126670A1 (es) * 2021-08-02 2023-11-01 Eurofarma Laboratorios S A COMPUESTOS N-ACILIDRAZÓNICOS INHIBIDORES DE Nav 1.7 Y/O Nav 1.8, SUS PROCESOS DE OBTENCIÓN, COMPOSICIONES, USOS, MÉTODOS DE TRATAMIENTO DE ESTOS Y KITS

Also Published As

Publication number Publication date
AR049472A1 (es) 2006-08-09

Similar Documents

Publication Publication Date Title
SG146657A1 (en) Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
MX2008001606A (es) Piperazinas substituidas como antagonistas de receptor de glutamato metabotropico.
JO2355B1 (en) Hereditary calcitonin polypeptide receptor antagonists
MX2007014405A (es) Novedosos derivados de oxadiazol y su uso como moduladores aloestericos positivos de los receptores de glutamato metabotropicos.
DE602006006712D1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
TW200612905A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
MY147767A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
MXPA06014721A (es) Derivados de alquinilo como moduladores de los receptores de glutamato metabotropico.
MX2009012579A (es) Antagonistas piridil piperidina del receptor de orexina.
TW200608960A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
TW200628452A (en) Substituted 2-anilinopyrimidines as cell-cycle-kinase or receptor-tyrosine-kinase inhibitors, their production and use as pharmaceutical agents
MA28279A1 (fr) Derives d'indole et utilisation de ceux-ci comme inhibiteurs de kinase, notamment des inhibiteurs de ikk2
TW200608966A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
MXPA06009475A (es) Derivados de quinazolina y usos terapeuticos de los mismos.
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
EP1858520A4 (en) CALCIUM CHANNEL ANTAGONISTS TYPE CHINAZOLINONE T
UA92670C2 (ru) Пиразолиновые соединения и их фармацевтическое применение, композиция на их основе
MY147677A (en) Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
TW200505904A (en) Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
WO2004087048A3 (en) Benzamide modulators of metabotropic glutamate receptors
ATE467632T1 (de) Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors
MX2007006387A (es) Derivados de piridina 3-substituidos como antagonistas h3.
WO2007067875A3 (en) Pyridinyl sulfonamide modulators of chemokine receptors
MX2007007027A (es) Derivados piperazinilpiridina como agentes anti-obesidad.
GB0524814D0 (en) Compounds